We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-13.33%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$98.7B
AUM Growth
-$13.4B
Cap. Flow
+$3.55B
Cap. Flow %
3.6%
Top 10 Hldgs %
17.21%
Holding
8,079
New
273
Increased
3,486
Reduced
3,341
Closed
357

Sector Composition

Rank Sector Weight
1 Technology 5.78%
2 Financials 5.08%
3 Healthcare 4.24%
4 Consumer Discretionary 4.16%
5 Energy 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICAD
6376
DELISTED
iCAD Inc
ICAD
$37K ﹤0.01%
9,900
KOPN icon
6377
Kopin
KOPN
$586M
$37K ﹤0.01%
36,839
-1,195
-3% -$2.15K
NUS icon
6378
CALL
Nu Skin
NUS
$257M
$37K ﹤0.01%
600
-1,200
-67% -$80.9K
PBJ icon
6379
Invesco Food & Beverage ETF
PBJ
$111M
$37K ﹤0.01%
1,235
PRNT icon
6380
The 3D Printing ETF
PRNT
$59M
$37K ﹤0.01%
1,867
YMAB
6381
DELISTED
Y-mAbs Therapeutics
YMAB
$37K ﹤0.01%
+1,834
New +$42.1K
PVLA
6382
Palvella Therapeutics
PVLA
$2.05B
$37K ﹤0.01%
170
-8
-4% -$2.48K
BLCM
6383
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$37K ﹤0.01%
1,278
-15
-1% -$665
PZN
6384
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$37K ﹤0.01%
4,320
-508
-11% -$4.93K
VSI
6385
DELISTED
Vitamin Shoppe Inc.
VSI
$37K ﹤0.01%
7,938
+7,854
+9,350% +$59K
ELGX
6386
DELISTED
Endologix Inc
ELGX
$37K ﹤0.01%
5,145
+3,788
+279% +$42.2K
WPG
6387
CALL
DELISTED
Washington Prime Group Inc.
WPG
$37K ﹤0.01%
844
-789
-48% -$44.2K
AOK icon
6388
iShares Core Conservative Allocation ETF
AOK
$783M
$36K ﹤0.01%
1,085
CHMG icon
6389
Chemung Financial Corp
CHMG
$394M
$36K ﹤0.01%
878
-28
-3% -$1.18K
GDO
6390
Western Asset Global Corporate Defined Opportunity Fund
GDO
$76.7M
$36K ﹤0.01%
2,398
-1,334
-36% -$20.5K
GIFI
6391
DELISTED
Gulf Island Fabrication
GIFI
$36K ﹤0.01%
5,029
+148
+3% +$1.25K
GORO icon
6392
CALL
Goldgroup Mining Inc.
GORO
$155M
$36K ﹤0.01%
9,000
+8,500
+1,700% +$38.3K
IPAY icon
6393
Amplify Mobile Payments ETF
IPAY
$173M
$36K ﹤0.01%
1,030
+430
+72% +$16.5K
LCNB icon
6394
LCNB Corp
LCNB
$289M
$36K ﹤0.01%
2,416
-72
-3% -$1.21K
LRMR icon
6395
Larimar Therapeutics
LRMR
$377M
$36K ﹤0.01%
606
-94
-13% -$9.28K
ODC icon
6396
Oil-Dri
ODC
$1.43B
$36K ﹤0.01%
2,696
+46
+2% +$704
ORRF icon
6397
Orrstown Financial Services
ORRF
$850M
$36K ﹤0.01%
1,998
-42
-2% -$891
POST icon
6398
PUT
Post Holdings
POST
$4.42B
$36K ﹤0.01%
611
-917
-60% -$55.2K
RYAAY icon
6399
PUT
Ryanair
RYAAY
$30B
$36K ﹤0.01%
1,250
-1,250
-50% -$39.9K
SPGM icon
6400
State Street SPDR Portfolio MSCI Global Stock Market ETF
SPGM
$1.68B
$36K ﹤0.01%
1,048
+66
+7% +$2.48K

Similar funds

Citigroup's Q4 2018 Portfolio in Review

As of Q4 2018, Citigroup held 8,079 positions worth $98.7B, down 12% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citigroup deployed $3.55B of net new capital in Q4 2018, opening 273 new positions and adding to 3,486 existing holdings. Its largest new stake was Takeda Pharmaceutical: 6,548,306 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.83B trimmed.

  • Citigroup's largest Q4 2018 buy was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
  • Citigroup added most to Energy Transfer Partners in Q4 2018, an estimated $560M increase.
  • Citigroup's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $1.83B.
  • Citigroup fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $677M.
  • Citigroup's ten largest holdings make up 17% of its $98.7B portfolio in Q4 2018.
  • Citigroup opened 273 new positions and closed 357 in Q4 2018.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $98.7B.

Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.